Browse diseases

…Background Oncogenic RAS mutations are prevalent in solid tumors and play a central role in driving immune evasion. While RAS in…

…ansion protocol, after which they were used to treat autologous melanoma cells ex vivo and in mice.Results By conventional and imaging f…

…them a promising cell source for cancer immunotherapy. However, solid tumors generate a unique microenvironment characterized by hypoxia, nu…

… constrained MDSC and M2 TAM expansion and tumor growth in both fibrosarcoma and KP models. These effects were abolished in Rorc fl/fl Lyz2-…

… tumors. Recently, TIL therapy received regulatory approval for melanoma, underscoring the need for robust, scalable product manufacturi…

…linical models and small retrospective cohorts of patients with lung cancer and melanoma. Here, we tested this effect in a large, multi-his…

…xpressed across a range of solid tumors, including melanoma and non-small cell lung cancer. The shared antigen targets in mRNA-4106 were selected through …

…nd T cell engager bispecifics, have had limited success against solid tumors. Hypotheses proposed to explain such limited success include an…

…ILs and peripheral blood mononuclear cells (PBMCs) derived from melanoma, head and neck, and lung cancer patients. Multiplexed, barcoded…

…ute lymphoblastic leukemia, Wilms tumor, Hodgkin’s disease, and testicular cancer. For those who are not being cured, additional therapies are ne…

…eathlessness, cough and fever while receiving pembrolizumab for melanoma. A CT pulmonary angiogram demonstrated small bilateral upper lo…

…tion). Meanwhile, the 5- year RSR of localised breast (female), melanoma, prostate and thyroid cancers all exceeded 99%.7 Similar statis…